initial findings of trial early february 2010

CLINICAL TRIAL OF ArTiMist ANTI MALARIA TREATMENT UPDATE

Eastland Medical Systems Ltd (ASX:EMS) announces today that it has received advice from Mr. Calvin Ross R&D Director of ProtoPharma Ltd our project consultant, and newly appointed Non-Executive Director of Eastland,
following hisThird visit to Rwanda to review progress of the trial, that he notes that the enrolment rate of children for the trial has been been faster than expected,
Based on this recent review it is now expected that we will be able to inform the market on the progress and initial findings of the trial in early February 2010.
.